We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Peripheral Blood Smears Still Need Evaluation

By LabMedica International staff writers
Posted on 22 Jun 2017
When the first automated hematology analyzers appeared in clinical laboratories in the 1960s, they ushered in a welcomed workflow change for bench technologists. More...
These automated analyzers replaced hemocytometers, though the need for differential counting remained.

This evolution in hematology workflows has continued to this day, with automated instruments performing ever more cellular analysis, resulting in more focused roles for technologists and pathologists. However, certain characteristics of peripheral blood morphology still do not lend themselves easily to evaluation by automated analyzers.

A clinical associate professor at the University of Florida (Gainesville, FL, USA) has written that one limitation that has remained constant from the earliest hematology analyzers to today’s cutting-edge flow cytometers is that a single cell still must pass through an aperture for analysis. In order to maintain laminar flow, the cell must also be sphered, which is most often accomplished with a proprietary sphering reagent. The exact classification of abnormally shaped red cells, for example, sickle cells, target cells, and schistocytes, still requires morphologic review of stained slides.

In addition red cell and white cell inclusions, particularly infectious organisms such as malaria or histoplasmosis, can be seen in stained blood smears but are not routinely detected by most automated hematology analyzers. Because of the extensive morphologic variability of many circulating hematologic malignancies, automated systems cannot precisely characterize these cells. Most analyzers, however, aid in characterizing these cells by pre-classifying them as abnormal (through large unstained cell classification or flagging) and prompting manual review of slides.

Analyzers that have digital morphology capabilities, such as the CellaVision or the Bloodhound systems, are inaugurating a new era of cellular analysis. As these instruments’ algorithms continue to be refined, this technology might evolve from a pre-classifier method to a more enhanced and robust method for precise characterization. The accuracy of an automated differential count depends on the analytical system used. However, given that most automated counters literally characterize thousands of white cells for each analysis, the classic 100-cell manual differential count in comparison falls short when it comes to precision. Sherri D. Flax, MD, published her article on June 1, 2017, in the journal Clinical Laboratory News.

Related Links:
University of Florida


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.